Blood transfusion is a life-saving intervention that has an essential role in patient management within health care systems. All Member States of the World Health Organization (WHO) endorsed World Health Assembly resolutions WHA28.72 (1) in 1975 and WHA58.13 (2) in 2005.
These commit them to the provision of adequate supplies of safe blood and blood products that are accessible to all patients who require transfusion either to save their lives or promote their continuing or improving health.
This Guide presents an introduction to basic concepts used in implementation research and describes the range of approaches and applications that it can be used for. The main aim of the Guide is to support the development of and demand for implementation research that is problem-focused, action-oriented and above all aligned with health system needs.
The year 2015 is a watershed moment in the battle against tuberculosis (TB). It marks the deadline for global TB targets set in the context of the Millennium Development Goals (MDGs), and is a year of transitions: from the MDGs to a new era of Sustainable Development Goals (SDGs), and from the Stop TB Strategy to the End TB Strategy. It is also two decades since WHO established a global TB monitoring system; since that time, 20 annual rounds of data collection have been completed.
Important recent changes or additions to guidelines for the management of tuberculosis (TB) in children have made it necessary to revise the first edition of Guidance for national tuberculosis programmes on the management of tuberculosis in children, published by WHO in 2006. Like the 2006 guidance, this document is targeted at national TB programmes, paediatricians and other health workers in low- and middle-income countries; it does not aim to outline recommendations for high-income countries with low TB prevalence. This distinction is especially important in the diagnostic approach and in contact investigation.
Reporting rate this week (71.3) represents an almost 14% decline in reporting rate from the previous week, 2019W13 (85.4%)
There were almost 28,000 malaria cases less this week (89,355) compared to 117,040 reported the previous week. There were 22deaths this week, the same as in the previous week. Hoima and Nabilatuk each reported the highest number (3 deaths)The West Nile districts of Zombo, Maracha, Moyo and Nebbi continue to report at least 10 cases per 1,000 popula-tion per week About 84% (108/128) of districts had less than 60% of facilities report their ACT stock status. A similar proportion (106/128) had less than 60% reported malaria cases
Reporting rate this week (85,4%) represents an almost 20% improvement in reporting rate from the pre-vious week, 2019W12 (65.9%)
There were almost 20,000 malaria cases more this week (117,040) ) compared to 97,077 reported the previous week. While there may be a real increase in the number of malaria cases, the improved report-ing rates may have played a role in this increase.
There were 29 deaths this week, over 4 times more than the previous week (7). Wakiso District reported 8 deaths in Wagagai Health Center IV. Nine districts reported over 10 confirmed malaria cases per 1,000 population. These include the West Nile districts of Zombo, Maracha, Moyo and Adjumani. Others in the North are Amuru, Gulu, Nwoya and Omoro Districts. Namayingo was the other district. About 23% (29/128) of districts treated ≥15% of patients who tested negative with an ACT
The purpose of this document is to provide guidance to national AIDS programmes and partners on the use of indicators to measure and report on the country response
The global AIDS response is at a precarious point—partial success in saving lives and stopping new HIV infections is giving way to complacency. At the halfway point to the 2020 targets, the pace of progress is not matching the global ambition. This report is a wake-up call—action now can still put us back on course to reach the 2020 targets.
Measured by the numbers of people who die each year, tuberculosis (TB) is the world’s deadliest infectious disease. Transmitted through the air and primarily targeting the lungs, this disease caused by a bacterial infection claims three lives every minute.1,2 In 2014, more than 9 million people became ill with TB and 1.5 million died, making it the world’s leading infectious killer.3 Worldwide over 2 billion people are infected with Mycobacterium tuberculosis, the bacterium that causes TB, comprising a source of the illness that must be addressed if we are to be successful in ending the disease.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO’s Member States and broader development goals set by the United Nations (UN).
The purpose of WHO’s Global Tuberculosis Report is to provide a comprehensive and up-to-date assessment of the TB epidemic and of progress in care and prevention at global, regional and country levels.1 This is done in the context of recommended global TB strategies and associated targets, and broader development goals. For the period 2016–2035, these are WHO’s End TB Strategy and the United Nations’ (UN) Sustainable Development Goals (SDGs), which share a common aim: to end the global TB epidemic.
The Sustainable Development Goals (SDGs) for 2030 were adopted by the United Nations in 2015. One of the targets is to end the global TB epidemic. The WHO End TB Strategy, approved by the World Health Assembly in 2014, calls for a 90% reduction in TB deaths and an 80% reduction in the TB incidence rate by 2030, compared with 2015.
